{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:59:21Z","timestamp":1790881161270,"version":"4.1.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The aim of this study was to determine the effect of smoking status on subsequent stroke risk in patients with minor ischemic stroke or TIA and to determine whether smoking modifies the effect of clopidogrel-based DAPT on subsequent stroke risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This was a post-hoc analysis of the Platelet Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) trial, which had a 90-day follow-up period. We used multivariable Cox regression and subgroup interaction analysis to determine the effect of smoking on the risk of subsequent ischemic stroke and major hemorrhage, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Data from 4877 participants enrolled in the POINT trial were analyzed. Among these, 1004 were current smokers and 3873 were non-smokers at the time of index event. Smoking was associated with a non-significant trend toward an increased risk of subsequent ischemic stroke during follow up (adjusted HR, 1.31 (95% CI, 0.97\u20131.78), p\u2009=\u20090.076). The effect of clopidogrel on ischemic stroke did not differ between non-smokers (HR, 0.74 (95% CI, 0.56\u20130.98), p\u2009=\u20090.03) and smokers (HR, 0.63 (95% CI, 0.37\u20131.05), p\u2009=\u20090.078), p for interaction\u2009=\u20090.572. Similarly, the effect of clopidogrel on major hemorrhage did not differ between non-smokers (hazard ratio, 1.67 (95% CI, 0.40\u20137.00), p\u2009=\u20090.481) and smokers (HR, 2.59 (95% CI, 1.08\u20136.21), p\u2009=\u20090.032), p for interaction\u2009=\u20090.613.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In this post-hoc analysis of the POINT trial we found that the effect of clopidogrel on reducing subsequent ischemic stroke as well as risk of major hemorrhage did not depend on smoking status, indicating that smokers benefit to a similar degree from DAPT as non-smokers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/23969873221148224","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T02:22:41Z","timestamp":1672280561000},"page":"328-333","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Subsequent ischemic stroke and tobacco smoking: A secondary analysis of the POINT trial"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4347-6514","authenticated-orcid":false,"given":"Adam Edward","family":"Lang","sequence":"first","affiliation":[{"name":"Department of Primary Care, McDonald Army Health Center, Fort Eustis, VA, USA 1"},{"name":"Department of Family Medicine and Population Health, Virginia Commonwealth University School of Medicine, Richmond, VA, USA 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8178-8597","authenticated-orcid":false,"given":"Adam","family":"de Havenon","sequence":"additional","affiliation":[{"name":"Department of Neurology, Clinical Neurosciences Center, University of Utah, Salt Lake City, UT, USA 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Mac Grory","sequence":"additional","affiliation":[{"name":"Department of Neurology, Duke University School of Medicine, Durham, NC, USA 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Henninger","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Massachusetts Medical School, Worcester, MA, USA 5"},{"name":"Department of Psychiatry, University of Massachusetts Medical School, Worcester, MA, USA 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqi","family":"Shu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Warren Alpert Medical School of Brown University, Providence, RI, USA 7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Furie","sequence":"additional","affiliation":[{"name":"Department of Neurology, Warren Alpert Medical School of Brown University, Providence, RI, USA 7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Donald","family":"Easton","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California, San Francisco, Sandler Neurosciences Center, San Francisco, CA, USA 8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California, San Francisco, Sandler Neurosciences Center, San Francisco, CA, USA 8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Claiborne","family":"Johnston","sequence":"additional","affiliation":[{"name":"Dell Medical School, University of Texas at Austin, Austin, TX, USA 9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Yaghi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Warren Alpert Medical School of Brown University, Providence, RI, USA 7"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"key":"2026012113110698700_bibr1-23969873221148224","doi-asserted-by":"crossref","first-page":"e14872","DOI":"10.1097\/MD.0000000000014872","article-title":"The relationship between smoking and stroke: a meta-analysis","volume":"98","author":"Pan","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"2026012113110698700_bibr2-23969873221148224","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1586\/erc.10.56","article-title":"Smoking and stroke: the more you smoke the more you stroke","volume":"8","author":"Shah","year":"2010","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2026012113110698700_bibr3-23969873221148224","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/CIRCULATIONAHA.116.024957","article-title":"Effect of clopidogrel by smoking status on secondary stroke prevention","volume":"135","author":"Ovbiagele","year":"2017","journal-title":"Circulation"},{"key":"2026012113110698700_bibr4-23969873221148224","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/ene.14171","article-title":"Impact of smoking on platelet function of ticagrelor versus clopidogrel in minor stroke or transient ischaemic attack","volume":"27","author":"Yang","year":"2020","journal-title":"Eur J Neurol"},{"key":"2026012113110698700_bibr5-23969873221148224","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA","volume":"379","author":"Johnston","year":"2018","journal-title":"N Engl J Med"},{"key":"2026012113110698700_bibr6-23969873221148224","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2147\/VHRM.S43909","article-title":"Platelet function testing to predict hyporesponsiveness to clopidogrel in patients with chest pain seen in the emergency department","volume":"9","author":"Sharma","year":"2013","journal-title":"Vasc Health Risk Manag"},{"key":"2026012113110698700_bibr7-23969873221148224","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40262-014-0230-6","article-title":"Clinical pharmacokinetics and pharmacodynamics of clopidogrel","volume":"54","author":"Jiang","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"2026012113110698700_bibr8-23969873221148224","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ahj.2013.04.008","article-title":"Racial disparity with on-treatment platelet reactivity in patients undergoing percutaneous coronary intervention","volume":"166","author":"Pendyala","year":"2013","journal-title":"Am Heart J"},{"key":"2026012113110698700_bibr9-23969873221148224","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.2337\/diabetes.54.8.2430","article-title":"Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment","volume":"54","author":"Angiolillo","year":"2005","journal-title":"Diabetes"},{"key":"2026012113110698700_bibr10-23969873221148224","doi-asserted-by":"crossref","first-page":"e010889","DOI":"10.1161\/JAHA.118.010889","article-title":"Effectiveness and safety of platelet ADP-P2Y12 receptor inhibitors influenced by smoking status: a systematic review and meta-analysis","volume":"8","author":"Liu","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"6_suppl_3","key":"2026012113110698700_bibr11-23969873221148224","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1161\/CIRCOUTCOMES.114.001244","article-title":"Smoking paradox in patients hospitalized with coronary artery disease or acute ischemic stroke","volume":"8","author":"Ali","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026012113110698700_bibr12-23969873221148224","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jacc.2013.10.043","article-title":"Impact of smoking on long-term outcomes in patients with atherosclerotic vascular disease treated with aspirin or clopidogrel: insights from the CAPRIE trial (Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events)","volume":"63","author":"Ferreiro","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026012113110698700_bibr13-23969873221148224","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1161\/CIRCULATIONAHA.109.866533","article-title":"Smoking, clopidogrel, and mortality in patients with established cardiovascular disease","volume":"120","author":"Berger","year":"2009","journal-title":"Circulation"},{"key":"2026012113110698700_bibr14-23969873221148224","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1161\/01.CIR.92.9.2432","article-title":"Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin","volume":"92","author":"Hung","year":"1995","journal-title":"Circulation"},{"key":"2026012113110698700_bibr15-23969873221148224","doi-asserted-by":"crossref","first-page":"E175","DOI":"10.1177\/1076029610394440","article-title":"Effect of cigarette smoking on platelet aggregation","volume":"17","author":"Pamukcu","year":"2011","journal-title":"Clin Appl Thromb Hemost"},{"key":"2026012113110698700_bibr16-23969873221148224","first-page":"1569","article-title":"Cigarette smoking inhibits the anti-platelet activity of aspirin in patients with coronary heart disease","volume":"124","author":"Li","year":"2011","journal-title":"Chin Med J (Engl)"},{"key":"2026012113110698700_bibr17-23969873221148224","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.amjcard.2006.03.029","article-title":"Frequency of aspirin resistance in a community hospital","volume":"98","author":"Mirkhel","year":"2006","journal-title":"Am J Cardiol"},{"key":"2026012113110698700_bibr18-23969873221148224","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1212\/WNL.0000000000004524","article-title":"Smoking cessation and outcome after ischemic stroke or TIA","volume":"89","author":"Epstein","year":"2017","journal-title":"Neurology"},{"key":"2026012113110698700_bibr19-23969873221148224","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/jama.1993.03500020066033","article-title":"Smoking cessation and decreased risk of stroke in women","volume":"269","author":"Kawachi","year":"1993","journal-title":"JAMA"},{"key":"2026012113110698700_bibr20-23969873221148224","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jama.1988.03720070025028","article-title":"Cigarette smoking as a risk factor for stroke. The Framingham Study","volume":"259","author":"Wolf","year":"1988","journal-title":"JAMA"},{"key":"2026012113110698700_bibr21-23969873221148224","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/jama.1995.03530020073035","article-title":"Smoking cessation and the risk of stroke in middle-aged men","volume":"274","author":"Wannamethee","year":"1995","journal-title":"JAMA"},{"key":"2026012113110698700_bibr22-23969873221148224","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"key":"2026012113110698700_bibr23-23969873221148224","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(05)66702-5","article-title":"A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack","volume":"366","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"key":"2026012113110698700_bibr24-23969873221148224","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1503\/cmaj.1030460","article-title":"Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease","volume":"170","author":"Eliasziw","year":"2004","journal-title":"CMAJ"},{"key":"2026012113110698700_bibr25-23969873221148224","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1503\/cmaj.1031349","article-title":"Management and outcomes of transient ischemic attacks in Ontario","volume":"170","author":"Gladstone","year":"2004","journal-title":"CMAJ"},{"key":"2026012113110698700_bibr26-23969873221148224","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/01.STR.0000158917.59233.b7","article-title":"Incidence and short-term prognosis of transient ischemic attack in a population-based study","volume":"36","author":"Kleindorfer","year":"2005","journal-title":"Stroke"},{"key":"2026012113110698700_bibr27-23969873221148224","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1001\/jama.284.22.2901","article-title":"Short-term prognosis after emergency department diagnosis of TIA","volume":"284","author":"Johnston","year":"2000","journal-title":"JAMA"},{"key":"2026012113110698700_bibr28-23969873221148224","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/01.STR.0000134416.89389.9d","article-title":"Stroke risk after transient ischemic attack in a population-based setting","volume":"35","author":"Lisabeth","year":"2004","journal-title":"Stroke"},{"key":"2026012113110698700_bibr29-23969873221148224","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1212\/01.WNL.0000129482.70315.2F","article-title":"The high risk of stroke immediately after transient ischemic attack: a population-based study","volume":"62","author":"Hill","year":"2004","journal-title":"Neurology"},{"key":"2026012113110698700_bibr30-23969873221148224","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.clpt.2004.04.003","article-title":"Time response of cytochrome P450 1A2 activity on cessation of heavy smoking","volume":"76","author":"Faber","year":"2004","journal-title":"Clin Pharmacol Ther"}],"container-title":["European Stroke Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23969873221148224","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/23969873221148224","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/esj\/article-pdf\/8\/1\/328\/64653492\/23969873221148224.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/esj\/article-pdf\/8\/1\/328\/64653492\/23969873221148224.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:12:48Z","timestamp":1769019168000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/esj\/article\/8\/1\/328\/8269118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3,1]]}},"URL":"https:\/\/doi.org\/10.1177\/23969873221148224","relation":{},"ISSN":["2396-9873","2396-9881"],"issn-type":[{"value":"2396-9873","type":"print"},{"value":"2396-9881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3,1]]},"published":{"date-parts":[[2023,3,1]]}}}